Diskussionsleiter: W. Haverkamp (Berlin), P. Lugenbiel (Heidelberg)
| (P421) | Novel ICD therapy reduction programming in primary and secondary prevention: reduced mortality and ICD therapies in a real-life cohort | |
| A. Schober, A. Schober, E. Ücer, U. Hubauer, S. Fredersdorf-Hahn, J. Seegers, L. S. Maier, C. G. Jungbauer (Regensburg) | ||
| (P422) | Therapie mit oralen Antikoagulantien bei geriatrischen Patienten – Ergebnisse des thrombEVAL-Studienprogramms | |
| R. Hardt, I. Gude, L. Eggebrecht, M. Nagler, C. Bickel, M. Lauterbach, H. Lamparter, K. Keller, M. Coldewey, C. Espinola-Klein, H. ten Cate, K. J. Lackner, T. Münzel, P. S. Wild, J. Prochaska (Mainz, Koblenz, Trier; Maastricht, NL) | ||
| (P423) | Succses of atrial fibrillation ablation in patients with paroxsysmal or persistent AF when comparing continuous with periodic discontinuous continuous follow-up | |
| U. Richter, M. Kronborg, J. Sitzy, L. Pu, J. Mayer, S. Ulbrich, T. Gaspar, Y. Huo, C. Piorkowski (Dresden; Aarhus, DK) | ||
| (P424) | From trials to clinical practice: true outcome of AF landmark trials and studies | |
| U. Richter, M. Kronborg, Y. Huo, J. Sitzy, L. Pu, J. Mayer, S. Ulbrich, T. Gaspar, C. Piorkowski (Dresden; Aarhus, DK) | ||
| (P425) | Safety after Continuous Use of Apixaban, Rivaroxaban and Dabigatran in Patients Undergoing Cardiac Implantable Electronic Device Implantation | |
| V. Tscholl, K. Ben Ltaief, P. Nagel, S. Biewener, S. Suhail, K. Lenz, U. Landmesser, M. Roser, M. Huemer (Berlin, Nürnberg) | ||
| (P426) | Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings | |
| M. Bettin, D. Dechering, S. Kochhäuser, N. Bode, F. Reinke, R. Dittrich, L. Eckardt, für die Studiengruppe: TRACK-AF (Münster, Osnabrück) |